menu
    • menu

    Company profile for PharmNovo

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Our Mission is to discover new, safe and effective drugs to make those lives considerably better. We combine smart chemistry and bioscience to discover new medicines to treat diseases of the nervous system. Our aim has been to develop biased agonists of the delta (δ) opioid receptor (DOR). Unlike the mu (μ) opioid receptor which is the major target of conventional opioid drugs, activating the DOR does not provide good acute...
    Our Mission is to discover new, safe and effective drugs to make those lives considerably better. We combine smart chemistry and bioscience to discover new medicines to treat diseases of the nervous system. Our aim has been to develop biased agonists of the delta (δ) opioid receptor (DOR). Unlike the mu (μ) opioid receptor which is the major target of conventional opioid drugs, activating the DOR does not provide good acute analgesia but produces excellent reversal of chronic pain in animal models. DOR agonists have none of the unwanted effects of conventional opioids.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    PharmNovoSweden Flag
    Country
    Country
    Sweden
    Address
    Address
    Medicon Village AB Scheeletorget 1 SE-223 81 Lund
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.pharmnovo.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pharmnovo Wraps Drug Manufacturing For PN6047 Phase Iia Study
    Pharmnovo Wraps Drug Manufacturing For PN6047 Phase Iia Study

    09 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-09/pharmnovo-completes-drug-product-manufacturing-for-phase-iia-study-of-pn6047

    PHARMIWEB
    09 Apr 2026
    Share Share
    Pharmnovo Initiates Ph 2a Trial Of PN6047 For Neuropathic Pain
    Pharmnovo Initiates Ph 2a Trial Of PN6047 For Neuropathic Pain

    09 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-09/pharmnovo-secures-cta-approval-in-spain-initiating-phase-iia-proof-of-concept-trial-of-pn6047-for-neuropathic-pain

    PHARMIWEB
    09 Oct 2025
    Share Share
    PharmNovo appoints CFO and Clinical Lead to strengthen the organisation
    PharmNovo appoints CFO and Clinical Lead to strengthen the organisation

    05 Sep 2022

    // CISION

    https://news.cision.com/pharmnovo/r/pharmnovo-appoints-cfo-and-clinical-lead-to-strengthen-the-organisation,c3625201

    CISION
    05 Sep 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search